文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

孕期接种疫苗的知识缺口与研究优先领域:加拿大母婴感染预防(PRIMED)联盟的视角

Knowledge gaps and research priorities regarding vaccination in pregnancy: A Canadian perspective from the prevention of infections in the maternal-infant dyad (PRIMED) consortium.
PubMed 文献 · Vaccine · 2025-08-11

加拿大PRIMED联盟于2017至2023年通过工作坊、在线调查和专家研讨会,与免疫利益相关方共同确定孕期接种研究优先领域,识别出SARS-CoV-2、巨细胞病毒、B组链球菌和呼吸道合胞病毒疫苗试验与免疫学研究,以及孕妇和提供者态度研究为高影响力方向,并据此提出研究路线图。

要点

  • 加拿大尚无国家层面的孕期接种研究议程来指导资金与研究。
  • 优先领域包括SARS-CoV-2、CMV、GBS和RSV的疫苗试验与免疫学研究。
  • 需研究孕妇、产前保健提供者和一线免疫提供者对孕期接种的态度。

核心结论

  • 作者推荐将孕期接种研究聚焦于SARS-CoV-2、CMV、GBS和RSV疫苗试验与免疫学研究,以及孕妇和提供者态度研究等高影响力领域。
  • 上述结果定义了围绕孕期接种形成连贯研究策略的路线图。

研究设计与样本

  • 2022年第二阶段为横断面调查,覆盖八种疾病和七种研究方法,发送给类似群体。
  • 2023年第三阶段举办三场专家工作坊,聚焦CMV、GBS和RSV三个优先领域。

主要发现

  • 第一阶段工作坊和调查针对39项百日咳相关研究缺口与优先事项,参与者包括研究者、免疫决策者、一线免疫人员、政策制定者和研究资助者。
  • 第二阶段横断面调查覆盖八种疾病和七种研究方法,发送给类似群体。
  • 第三阶段三场专家工作坊聚焦第二阶段确定的CMV、GBS和RSV三个优先领域。
  • 识别出的研究优先事项包括SARS-CoV-2、CMV、GBS和RSV疫苗试验与免疫学研究。
  • 识别出需研究孕妇及其他孕期人群、产前保健提供者和一线免疫提供者对孕期接种的态度。

临床怎么用

  • 作者推荐将孕期接种研究聚焦于SARS-CoV-2、CMV、GBS和RSV疫苗试验与免疫学研究以及孕妇和提供者态度研究等高影响力领域。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vaccination in pregnancy is a safe and effective method for protecting both the pregnant woman/person and their infant from communicable diseases. Despite a growing body of evidence of the benefits of vaccination during pregnancy and the widespread introduction of vaccines during pregnancy for influenza, pertussis, and COVID-19, there is no national research agenda in Canada to guide funding and research. We sought to create a roadmap for Canadian vaccination in pregnancy research. During 2017-2023, working with immunization stakeholders using in-person and virtual workshops and online surveys, we identified priorities for Canadian research on vaccination in pregnancy. Stage one (2017-18) included a workshop, followed by a survey, regarding 39 pertussis-related research gaps and priorities, and included researchers, immunization decision-makers, frontline immunizers, policymakers, and research funders. Stage two (2022) was a cross-sectional survey across eight diseases and seven research approaches sent to a similar group. During stage three (2023), we held three expert workshops focusing on three priority areas identified during stage two, including cytomegalovirus (CMV), group B streptococcus (GBS), and respiratory syncytial virus (RSV). Our work identified several research priorities, including SARS-CoV-2, CMV, GBS, and RSV vaccine trials and immunologic studies, and the need for research into the attitudes of pregnant women and other pregnant people, prenatal care providers, and frontline immunization providers toward vaccination during pregnancy. As such, we recommend focusing vaccination in pregnancy research toward these high-impact areas. These results define a roadmap for a cohesive research strategy around vaccination in pregnancy.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hunter OF, McClymont E, Lau O, et al. Knowledge gaps and research priorities regarding vaccination in pregnancy: A Canadian perspective from the prevention of infections in the maternal-infant dyad (PRIMED) consortium. Vaccine. 2025. PMID: 40795701. doi:10.1016/j.vaccine.2025.127594

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。